Evaluation of Mammography Performance in the United States: The Breast Cancer Surveillance Consortium

Seminars in Breast Disease

Volumn 10, Issue 2, 2007, Pages 89-101

  Yabroff, K Robin ^a   Ballard Barbash, Rachel ^a   Carney, Patricia ^b   Barlow, William ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c USA   (United States)

Author keywords

breast neoplasms; mammography; mass screening; surveillance

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SCREENING; CLINICAL PRACTICE; CLINICAL RESEARCH; EVALUATION; HEALTH CARE QUALITY; HUMAN; PATHOLOGIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RADIOLOGIST; XEROMAMMOGRAPHY;

EID: 36448949736     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sembd.2007.09.006     Document Type: Article

References (66)

1. American Cancer Society. Cancer Facts & Figures 2003. 1-32 (2003), American Cancer Society, Atlanta, GA
2. Ries L.A.G., Kosary C.L., Hankey B.F., and Edwards B.K. SEER Cancer Statistic Review, 1973-1996 (1999), National Cancer Institute, Bethesda Maryland
3. Eley J.W., Hill H.A., Chen V.W., et al. Racial differences in survival from breast cancer Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272 (1994) 947-954
4. Hiatt R.A., and Rimer B.K. A new era for cancer prevention and control research. Cancer Epidemiol Biomarkers Prev 8 (1999) 955-956
5. Shapiro S., Venet W., Strax P., et al. Ten-to-fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 69 (1982) 349
6. Tabar L., Fagerberg G., Gad A., et al. Reduction in mortality from breast cancer after mass screening with mammograpy: randomized trial form the breast cancer screening working group of the swedish national board of health and welfare. Lancet 1 (1985) 829-832
7. Roberts M.M., Alexander F.E., Anderson T.J., et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 335 (1990) 241-246
8. Frisell J., Eklund G., Hellstorm L., et al. Randomized study of mammography screening: preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18 (1991) 49-56
9. Fletcher S.W., Black W., Harris R., et al. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85 (1993) 1644-1656
10. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. (ed 2) (1989), Williams & Wilkins, Baltimore, MD
11. American Cancer Society. Guidelines for the cancer related checkup. Recommendations and rationale. CA Cancer J Clin 30 (1980) 194
12. Breen N., Wagener D.K., Brown M.L., et al. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 national health interview surveys. J Natl Cancer Inst 93 (2001) 1704-1713
13. Swan J., Breen N., Coates R.J., et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97 (2003) 1528-1540
14. Newell S.A., Girgis A., Sanson-Fisher R.W., et al. The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. Am J Prev Med 17 (1999) 211-229
15. Gordon N.P., Hiatt R.A., and Lampert D.I. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 85 (1993) 566-570
16. Hiatt R.A., Perez-Stable E.J., Quesenberry Jr. C.P., et al. Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non Hispanic white health plan members in northern California. Prev Med 24 (1995) 278-285
17. Paskett E.D., Tatum C.M., Mack D.W., et al. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 5 (1996) 721-726
18. Zapka J.G., Bigelow C., Hurley T., et al. Mammography use among sociodemographically diverse women: the accuracy of self-report. Am J Public Health 86 (1996) 1016-1021
19. Haus A.G. Historical technical developments in mammography. Technol Cancer Res Treat 1 (2002) 119-126
20. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351 (1998) 1451-1467
21. Early Breast Cancer Trialists' Collaborative Group. Multi-agent chemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352 (1998) 930-942
22. Brown M.L., and Houn F. Quality assurance audits of community screening mammography practices: importance of active follow-up for data collection and outcome assessment. AJR Am J Roentgenol 163 (1994) 825-829
23. Ballard-Barbash R., Taplin S.H., Yankaskas B.C., et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169 (1997) 1001-1008
24. Gotzsche P.C., and Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet 355 (2000) 129-134
25. Humphrey L.L., Helfand M., Chan B.K., et al. Breast cancer screening: a summary of evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 347-360
26. Smith R.A., Saslow D., Sawyer K.A., et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 53 (2003) 141-169
27. D'Orsi C.J., Bassett L.W., Feig S., et al. American College of Radiology (ACR): Breast Imaging Reporting and Data System (BI-RADS). (ed 3) (1998), American College of Radiology, Reston, VA
28. Carney P.A., Geller B.M., Moffett H., et al. Current medicolegal and confidentiality issues in large, multicenter research programs. Am J Epidemiol 152 (2000) 371-378
29. Taplin S.H., Ichikawa L.E., Kerlikowske K., et al. Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology 222 (2002) 529-535
30. Barlow W.E., Lehman C.D., Zheng Y., et al. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst 94 (2002) 1151-1159
31. Geller B.M., Barlow W.E., Ballard-Barbash R., et al. Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease. Radiology 222 (2002) 536-542
32. Geller B.M., Ichikawa L.E., Buist D.S.M., et al. Improving the concordance of mammography assessment and management recommendations. Radiology (2006) in press
33. Smith-Bindman R., Chu P.W., Miglioretti D.L., et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA 290 (2003) 2129-2137
34. Geller B.M., Ichikawa L.E., Buist D.S., et al. Breast Cancer Surveillance Consortium. Improving the concordance of mammography assessment and management recommendations. Radiology 241 (2006) 67-75
35. Rosenberg R.D., Hunt W.C., Williamson M.R., et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 209 (1998) 511-518
36. Kerlikowske K., Grady D., Barclay J., et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276 (1996) 33-38
37. Carney P.A., Miglioretti D.L., Yankaskas B.C., et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138 (2003) 168-175
38. El-Bastawissi A.Y., White E., Mandelson M.T., et al. Variation in mammographic breast density by race. Ann Epidemiol 11 (2001) 257-263
39. Kerlikowske K., Carney P.A., Geller B., et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 133 (2000) 855-863
40. Kerlikowske K., Grady D., Barclay J., et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst 90 (1998) 1801-1809
41. Beam C.A., Conant E.F., and Sickles E.A. Association of volume and volume-independent factors with accuracy in screening mammogram interpretation. J Natl Cancer Inst 95 (2003) 282-290
42. Beam C.A., Conant E.F., and Sickles E.A. Factors affecting radiologist inconsistency in screening mammography. Acad Radiol 9 (2002) 531-540
43. Beam C.A., Layde P.M., and Sullivan D.C. Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample. Arch Intern Med 156 (1996) 209-213
44. Elmore J.G., Wells C.K., Lee C.H., et al. Variability in radiologist's interpretation of mammograms. N Engl J Med 331 (1994) 1493-1499
45. Yankaskas B.C., Cleveland R.J., Schell M.J., et al. Association of recall rates with sensitivity and positive predictive values of screening mammography. AJR Am J Roentgenol 177 (2001) 543-549
46. Sickles E.A., Wolverton D.E., and Dee K.E. Performance parameters for screening and diagnostic mammography: specialist and general radiologists. Radiology 224 (2002) 861-869
47. Barlow W.E., Chi C., Carney P.A., et al. Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst 96 (2004) 1840-1850
48. Smith-Bindman R., Chu P., Miglioretti D.L., et al. Physician predictors of mammographic accuracy. J Natl Cancer Inst 97 (2005) 358-367
49. Improving Breast Imaging Quality Standards (2006), Institute of Medicine, The National Academies Press, Washington, DC
50. Mandelson M.T., Oestreicher N., Porter P.P., et al. Breast density as a predictor of mammographic detection: comparison of interval vs. screen-detected cancers. J Natl Cancer Inst 92 (2000) 1081-1087
51. Porter P.L., El-Bastawissi A.Y., Mandelson M.T., et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 91 (1999) 2020-2028
52. Gilliland F.D., Joste N., Stauber P.M., et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 92 (2000) 743-749
53. Ernster V.L., Barclay J., Kerlikowske K., et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275 (1996) 913-918
54. Ernster V.L., Barclay J., Kerlikowske K., et al. Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance, Epidemiology and End Results program. Arch Intern Med 160 (2000) 953-958
55. Ernster V.L., Ballard-Barbash R., Barlow W.E., et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94 (2002) 1546-1554
56. Waldman F.M., DeVries S., Chew K.L., et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92 (2000) 313-320
57. Blanks R.G., Moss S.M., McGahan C.E., et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. Br Med J 321 (2000) 665-669
58. Hakama M., Pukkala E., Heikkila M., et al. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. Br Med J 314 (1997) 864-867
59. Jonsson H., Nystrom L., Tornberg S., et al. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8 (2001) 152-160
60. Barchielli A., and Paci E. Trends in breast cancer mortality, incidence, and survival, and mammographic screening in Tuscany. Italy Cancer Causes Control 12 (2001) 249-255
61. Tabar L., Vitak B., Chen H.H., et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91 (2001) 1724-1731
62. Otto S.J., Fracheboud J., Looman C.W., et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361 (2003) 1411-1417
63. Kelsey J.L., and Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 17 (1996) 47-67
64. Madigan M.P., Ziegler R.G., Benichou J., et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87 (1995) 1681-1685
65. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 (1989) 1879-1886
66. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90 (1998) 1371-1388